article thumbnail

A2 Biotherapeutics, Founded By Amgen Vets, Gets $57M For Cell Therapies

socalTECH

Agoura Hills-based A2 Biotherapeutics , a biotechnology firm started by veterans of Amgen which is developing cell therapies for cancer patients, has raised $57M in a Series A funding round, the company said this week. The funding came from The Column Group, Vida Ventures, Samsara BioCapital and Nextech Invest.